Cochlear Investor Relations Material
Latest events
H2 2024
Cochlear
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Cochlear Limited
Access all reports
Cochlear Limited is a developer, manufacturer and marketer of implantable hearing solutions for adults and children worldwide. It provides in-the-ear devices that restore functional hearing to people with sensorineural, or ‘brain-based’, hearing loss; a condition caused by damage to the inner ear or auditory nerve. Cochlear products are sold through OEM partnerships with medical device companies, who integrate them into their products and distribute them through their own sales networks to physicians worldwide. Customers for these products include audiologists and surgeons involved in cochlear implant surgery, as well as hospitals, government health agencies and other users of off-the-shelf implanted components such as hearing aid dispensers.
Key slides for Cochlear Limited
H1 2024
Cochlear Limited
H2 2024
Cochlear Limited
Latest articles
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
COH
Country
🇦🇺 Australia